ArticleNeurology and therapy2021

Multiple Sclerosis Patients Treated With Diroximel Fumarate in the Real-World Setting Have High Rates of Persistence and Adherence.

Jacob Liseno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.